The exercise period for Moberg Pharma's warrants of series 2020:1 begins today
STOCKHOLM, March 16[th], 2022. Today the exercise period for Moberg Pharma AB (publ)'s ("Moberg Pharma" or the "Company") warrants of series 2020:1 begins. The exercise period runs during the period from and including 16 March 2022 up to and including 29 March 2022. The last day for trading in warrants of series 2020:1 on Nasdaq Stockholm is 25 March 2022.In 2020, Moberg Pharma carried out a rights issue of units. Each unit consisted of one (1) ordinary share and one (1) warrant in Moberg Pharma. Two (2) warrants entitle the holder to subscribe for one (1) new ordinary share in Moberg